Regulation of APOBEC3B catalyzed mutation in ovarian cancer

Thumbnail Image

Persistent link to this item

View Statistics

Journal Title

Journal ISSN

Volume Title


Regulation of APOBEC3B catalyzed mutation in ovarian cancer

Published Date




Thesis or Dissertation


Cancer is the second highest cause of death in the United States. A greater understanding of the underlying causes of this disease is critical to improve patient outcomes. For years, researchers have known that cancer is primarily a genetic disease, caused by mutations that can activate oncogenes and inactivate tumor suppressors. Several studies have also shown that UV radiation, smoking and certain defects in DNA repair cause some of the mutations that lead to cancer, but the sources of mutations found in many tumor types are yet to be explained. Here, we build upon our initial finding that APOBEC3B is a source of mutation in breast cancer by defining its role in ovarian cancer. Parallel analyses looking globally at mutation in cancer have shown that APOBEC3B also contributes to mutation in several other tumor types. Additional studies have elucidated a major signaling mechanism that regulates APOBEC3B expression in cancer. While many efforts have been made to directly inhibit APOBEC3B enzymatic activity, the advances described here have the potential to inform alternative therapeutic strategies aimed at transcriptionally downregulating APOBEC3B to slow tumor evolution and improve the durability of conventional anti-cancer drugs. Ultimately, a more comprehensive understanding of the basic biology of APOBEC3B catalyzed mutagenesis in cancer will translate to larger impacts in the clinical arena.


University of Minnesota Ph.D. dissertation. August 2015. Major: Microbiology, Immunology and Cancer Biology. Advisor: Reuben Harris. 1 computer file (PDF); viii, 149 pages.

Related to




Series/Report Number

Funding information

Isbn identifier

Doi identifier

Previously Published Citation

Suggested citation

Leonard, Brandon. (2015). Regulation of APOBEC3B catalyzed mutation in ovarian cancer. Retrieved from the University Digital Conservancy,

Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.